Stanford researchers have discovered an AI-identified natural molecule that dramatically suppresses appetite and promotes fat loss in animals, potentially offering an Ozempic-like weight-loss treatment without common digestive side effects or significant muscle loss. Called BRP, the molecule reduced food intake by up to 50% and targets a different brain pathway, raising hopes for a more precise obesity treatment if future human trials prove successful.
This story was curated by Byte Panorama from reporting published by All Top News -- ScienceDaily. Our summary condenses the essential facts available at the time of collection; it does not reproduce the full article. Details, quotes and later updates may appear in the original report.